

HY-168913 · 50 mg
MedChemExpress · Cat: HY-168913
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ctt2274.htmlDescription
CTT2274 is a prodrug of MMAE HY-15162 . CTT2274 is composed of a prostate-specific membrane antigen PSMA -binding scaffold, a biphenyl motif, a pH-sensitive phosphoramidate linker, and MMAE payload. CTT2274 shows selective binding to PSMA and delivers MMAE. CTT2274 inhibits prostate cancer.







